Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery

Drug Delivery

Volumn 22, Issue 2, 2015, Pages 168-181

  Shi, Jifeng ^a   Zhang, Jialin ^b   Shen, Yan ^a   Tang, Lidan ^c   Zhao, Jin ^c   Tu, Jiasheng ^a   Tian, Yu ^a   Feng, Yanli ^c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE FOR FOOD AND DRUG CONTROL   (China)

^c China Coal Science and Industry Group Chongqing Research Institute Co   (China)

Author keywords

Antitumor efficacy; Arginine; Docetaxel; Methoxy (polyethylene glycol) block poly (D, L lactide); Polymeric micelles

Indexed keywords

AMPHOPHILE; ARGININE; COPOLYMER; DOCETAXEL; GLUCOSE; MACROGOL; METHOXY(POLYETHYLENE GLYCOL) BLOCK POLY(LACTIDE); UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG CARRIER; MACROGOL DERIVATIVE; METHOXY POLY(ETHYLENE GLYCOL)-BLOCK-POLY(LACTIC ACID); MICELLE; POLYESTER; TAXOID;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BEAGLE; CANCER PATIENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; FEMALE; FREEZE DRYING; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VIVO STUDY; MALE; MICELLE; MOLECULAR STABILITY; MOUSE; NONHUMAN; PARTICLE SIZE; POWDER; PRIORITY JOURNAL; SINGLE DRUG DOSE; STATIC ELECTRICITY; ADVERSE EFFECTS; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA, LEWIS LUNG; CHEMISTRY; DOG; INBRED STRAIN; METABOLIC CLEARANCE RATE; RANDOMIZATION; TISSUE DISTRIBUTION; TOXICITY TESTING;

ANIMALS; ANIMALS, INBRED STRAINS; ANTINEOPLASTIC AGENTS; ARGININE; CARCINOMA, LEWIS LUNG; DOGS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; MALE; METABOLIC CLEARANCE RATE; MICE; MICELLES; NEOPLASM TRANSPLANTATION; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; RANDOM ALLOCATION; TAXOIDS; TISSUE DISTRIBUTION; TOXICITY TESTS, ACUTE;

EID: 84921689882     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.849779     Document Type: Article

References (27)

1. Asadi H, Rostamizadeh K, Salari D, et al. (2011). Preparation and characterization of tri-block poly(lactide)-poly(ethylene glycol)-poly(lactide) nanogels for controlled release of naltrexone. Int J Pharm 416:356-64.
2. Baker J, Ajani J, Scotté F, et al. (2009). Docetaxel-related side effects and their management. Eur J Oncol Nurs 13:49-59.
3. Benahmed A, Ranger M, Leroux J. (2001). Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrroli-done)-block-poly(D,L-lactide). Pharm Res 18:323-8.
4. Cho H, Indig GL, Weichert J, et al. (2012). In vivo cancer imaging by poly(ethylene glycol)-b-poly(ε-caprolactone) micelles containing a near-infrared probe. Nanomed Nanotechnol 8:228-36.
5. Dong Y, Feng SS. (2004). Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25:2843-9.
6. Gaucher G, Marchessault RH, Leroux JC. (2010). Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Control Release 143:2-12.
7. Hales M, Barner-Kowollik C, Davis TP, et al. (2004). Shell-cross-linked vesicles synthesized from block copolymers of poly(d,l-lactide) and poly(N-isopropyl acrylamide) as thermoresponsive nanocontainers. Langmuir 20:10809-17.
8. He C, Hu Y, Yin L, et al. (2010). Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:3657-66.
9. Immordino ML, Brusa P, Arpicco S, et al. (2003). Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J Control Release 91:417-29.
10. Kataoka K, Matsumoto T, Yokoyama M, et al. (2000). Doxorubicinloaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control release 64:143-53.
11. Kim SY, Shin IG, Lee YM. (1998). Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and dl-lactide block copolymer as novel drug carriers. J Control Release 56:197-208.
12. Krimmer SG, Pan H, Liu J, et al. (2011). Synthesis and characterization of poly("-caprolactone)-block-poly[N- (2-hydroxypropyl)methacrylamide] micelles for drug delivery. Macromol Biosci 11:1041-51.
13. Kumar D, Tomar RS, Deolia SK, et al. (2007). Isolation and characterization of degradation impurities in docetaxel drug substance and its formulation. J Pharmaceut Biomed 43:1228-35.
14. La SB, Okano T, Kataoka K. (1996). Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(b-benzyl L-aspartate) block copolymer micelles. J Pharm Sci 85:85-90.
15. Li Y, Xiao K, Luo J, et al. (2010). A novel size-tunable nanocarrier system for targeted anticancer drug delivery. J Control Release 144: 314-23.
16. Liggins RT, Burt HM. (2002). Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliver Rev 54:191-202.
17. Liu D, Liu Z, Wang L, et al. (2011). Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces 85:262-9.
18. Miyata K, Christie RJ, Kataoka K. (2011). Polymeric micelles for nanoscale drug delivery. React Funct Polym 71:227-34.
19. Schmuck C, Graupner S. (2005). Amino acid binding in water by a new guanidiniocarbonyl pyrrole dication: the effect of the experimental conditions on complex stability and stoichiometry. Tetrahedron Lett 46:1295-8.
20. Shenoy DB, Amiji MM. (2005). Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 293:261-70.
21. Tong SW, Xiang B, Dong DW, et al. (2012). Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Int J Pharm 434:413-19.
22. Vasu Dev R, Moses Babu J, Vyas K, et al. (2006). Isolation and characterization of impurities in docetaxel. J Pharmaceut Biomed 40: 614-22.
23. Yin YM, Cui FD, Mu CF, et al. (2009). Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release 140:86-94.
24. Yoo HS, Park TG. (2001). Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release 70:63-70.
25. Zareie HM, Kaitian X, Pişkin E. (1996). STM images of PDLLA-PEG copolymer micelles. Colloid Surface A 112:19-24.
26. Zhang X, Jackson JK, Burt HM. (1996). Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm 132: 195-206.
27. Zhang X, Li Y, Chen X, et al. (2005). Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate. Biomaterials 26:2121-8.